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Background: Patients with multiple sclerosis (MS) have been reported to be at higher risk of fracture than other
people. We sought to test this hypothesis in a large database of hospital admissions in England.
Methods: We analysed a database of linked statistical records of hospital admissions and death certificates for the
whole of England (1999–2010). Rate ratios for fractures were determined, comparing fracture rates in a cohort of all
people in England admitted with MS and rates in a comparison cohort.
Results: Significantly elevated risk for all fractures was found in patients with MS (rate ratio (RR) = 1.99, 95%
confidence interval (CI) = 1.93-2.05)). Risks were particularly high for femoral fractures (femoral neck fracture
RR = 2.79 (2.65-2.93); femoral shaft fracture RR 6.69 (6.12-7.29)), and fractures of the tibia or ankle RR = 2.81
(2.66-2.96).
Conclusions: Patients with MS have an increased risk of fractures. Caregivers should aim to optimize bone health
in MS patients.
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Multiple sclerosis (MS) is a common, complex, immune-
mediated disorder of the central nervous system (CNS)
characterised by myelin loss, varying degrees of axonal
pathology and progressive neurological dysfunction [1].
Patients with MS may be at risk of fracture due to low
bone mineral density [2] and an elevated risk of falling
[3]. Osteoporosis occurs more frequently among patients
with MS, possibly as a result of immobility, imbalance,
progressive disability or other undetermined yet factors
[4]. An increased risk of falling may arise from imbal-
ance or disability [3].
Previous studies have investigated the risk of fracture
in patients with MS [5]. The Danish MS register found a
40% increased risk [6] and a study from the United
Kingdom (UK) using the General Practice Research
Database (GPRD) observed a 20% elevated risk for all
fractures [7]. To investigate the association further, we
undertook a record linkage study to determine the risk* Correspondence: michael.goldacre@dph.ox.ac.uk
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distribution, and reproduction in any mediumof fracture in individuals with MS using an English na-
tional linked Hospital Episode Statistics (HES) dataset.Methods
Population and data
We used the complete dataset of English national Hos-
pital Episode Statistics (HES) (1999–2010) covering the
population of England of about 50 million people. Death
data derive from death certificates. The dataset used in
this study, in which successive records for each individ-
ual were linked together, was constructed by the Oxford
record linkage group. The data used are not publicly
available. The dataset of Hospital Episode Statistics was
provided by the NHS Health and Social Care Informa-
tion Centre; the mortality data were provided by the
Office for National Statistics; and approval to analyse the
datasets used in this study was given by the Central and
South Bristol Research Ethics Committee (REC number
04/Q2006/176).
A cohort of people with a hospital admission or record
of day case care for MS was constructed for those with a
diagnosis of MS, as a reason for hospital care, by identi-
fying the first admission, or episode of day case care, forentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Number of people admitted to hospital for
multiple sclerosis by age group, percentage female, and
the matching ratio which gives the number of people in
the reference cohort† in each age group per person with
multiple sclerosis in the same age group‡
Age group (years) Number of people Female (%) Matching ratio
<15 82 56.1 15615
15-24 1942 69.5 511
25-34 9003 71.0 139
35-44 17524 70.4 69
45-54 22398 70.1 36
55-64 18957 66.2 41
65-74 11296 67.1 63
75+ 6671 71.7 123
Total 87873 69.1 89
† Conditions used in the reference cohort, with Office of Population, Censuses
and Surveys (OPCS) code edition 4 for operations and ICD-10 code for
diagnosis: appendectomy (OPCS4 H01-H03); bunion (M20.1); cataract (H25);
deflected nasal septum and nasal polyp (J33, J34.2); dilation and curettage
(OPCS Q10-Q11); haemorrhoids (I84); impacted tooth and other disorders of
teeth (K00-K03); in-growing toenail and other diseases of nail (L60); inguinal
hernia (K40); internal derangement of knee (M23); otitis externa and otitis
media (H60-H67); sebaceous cyst (L72.1); squint (H49-H51); tonsillectomy and
adenoidectomy (OPCS4 E20, F34, F36); upper respiratory tract infections (J00-
J06); varicose veins (I83); vasectomy, female sterilisation and other
contraceptive management (Z30).
‡ For example, in the age group 15–24, there are 992362 control people (511
controls for each of the 1942 people with MS in that age group). In the age
group 45–54 there are 806328 controls (36 controls for each of the 22398
people with MS in that age group).
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ing the study period of 1999 to 2010. The International
Classification of Disease (ICD) code used for MS was
G35. The ICD codes used for fracture were S020, S029,
S120-S129, S220-S229, S320-S329, S420-S429, S520-
S529, S620-S628, S720-S729, S820-S829, S920-S929,
T020-T029, T080-T089, T100 and T120 in the tenth re-
vision; and equivalent codes for the ninth. A reference
cohort was constructed by identifying the first admission
for each individual with various other, mainly minor
medical and surgical conditions (see Table, footnote), as
used by us in other studies of associations between dis-
eases [8,9]. In its design, the standard epidemiological
practice was followed, when hospital controls are used,
of using a diverse range of conditions, rather than rely-
ing on a narrow range (in case the latter are themselves
atypical in their risk of subsequent disease). People were
excluded from the MS or reference cohort if they had an
admission for fracture either before or at the same time
as the admission for MS or the reference condition.
We then searched the linked database for any subse-
quent NHS hospital care for, or death from, fracture in
these cohorts. We considered that rates of fracture in
the reference cohort would approximate those in the
general population of England while allowing for migra-
tion in and out of it (data on migration of individuals
were not available).
Statistical methods
We calculated rates of fracture based on person-years.
For each fracture site separately, we took “date of entry”
into each cohort as the date of first admission for MS,
or reference condition, and “date of exit” as the date of
first record of each type of fracture, death, or the end of
data collection (31st December 2010), whichever was the
earliest. We first calculated rates for each fracture, strati-
fied and then standardised by age (in five-year age
groups), sex, calendar year of first recorded admission,
region of residence, and quintile of patients’ Index of
Deprivation score (as a measure of socio-economic sta-
tus). We used the indirect method of standardisation,
using the combined MS and reference cohorts as the
standard population. The stratum-specific rates in the
combined MS and reference cohorts were then applied
to the number of people in each stratum in the MS co-
hort, separately, and then to those in the reference co-
hort, to give an observed (O) and expected (E) number
of people with each fracture in each of the two cohorts.
The ratio of the standardised rate of occurrence of frac-
ture in the MS cohort was calculated relative to that in
the reference cohort using the formula (OMS/EMS)/(Oref/
Eref ). The confidence interval for the rate ratio and χ2
statistics for its significance were calculated as described
elsewhere [10]. The analyses were run using a suite ofprograms developed ‘in house’ using SAS 9 software
(SAS Institute, Cary, NC, USA). We have given exact p
values so that readers can judge what level of statistical
significance each finding has. A full Bonferroni correc-
tion for testing multiple comparisons across eleven frac-
ture sites would take as significant an exact p value of
0.004 (i.e. p = 0.05/11).
Results
Table 1 shows the number of people in the study who
were admitted to hospital with MS, in each age group,
and it shows the percentage in each group who were fe-
male. It also shows the matching ratio, expressed as the
number of controls in each age group per individual
with MS in the group. All eligible controls were used
within each age group to give ‘expected’ numbers of
each fracture within each age group with which the
observed numbers within the age group were compared
(given the use of age-standardisation, nothing is gained
by discarding controls to try to give equal matching
ratios in each age group). Numbers of cases of MS in
people under 35 years of age were very small (though
numbers of controls were not); accordingly, the calcula-
tions of the observed numbers and expected numbers of
each fracture within these age strata were also very small
and added little to the overall rate ratio. The matching
Table 2 Rate ratios and 95% confidence intervals (CIs) for fractures in people with multiple sclerosis compared with
the reference cohort
Fracture (ICD code†) Observed Expected Rate Ratio
(95% confidence interval)
Exact P value
All fractures‡ 4414 2238.3 1.99 (1.93-2.05) <0.001*
Ribs (S22.2-S22.4 ) 161 130 1.24 (1.06-1.45) 0.007
Clavicle (S42.0) 83 52.6 1.59 (1.26-1.97) <0.001*
Humerus (S42.2-S42.4, S42.7) 415 204.2 2.05 (1.86-2.26) <0.001*
Forearm (S52) 448 493.5 0.91 (0.82-1.00) 0.042
Wrist/Hand (S62) 157 188.1 0.83 (0.71-0.98) 0.025
Pelvis/Lumbar spine (S32.0-S32.8) 293 187.7 1.57 (1.39-1.76) <0.001*
Tibia/Ankle (S82) 1393 506.1 2.81 (2.66-2.96) <0.001*
Foot (S92) 194 95.5 2.05 (1.77-2.37) <0.001*
Femur - neck of (S72.0-S72.2) 1579 574.2 2.79 (2.65-2.93) <0.001*
Femur - other (S72.3-S72.8) 543 85.8 6.69 (6.12-7.29) <0.001*
Femur - unspecified (S72.9) 88 18.5 4.91 (3.92-6.08) <0.001*
Fractures up to 1 year after first MS admission Observed Expected Rate Ratio
(95% confidence interval)
Exact P value
All fractures‡ 717 373.4 1.94 (1.80-2.08) <0.001*
Ribs (S22.2-S22.4) 22 20.2 1.09 (0.68-1.65) 0.779
Clavicle (S42.0) 11 7.7 1.43 (0.71-2.57) 0.319
Humerus (S42.2-S42.4, S42.7) 76 28.3 2.72 (2.14-3.41) <0.001*
Forearm (S52) 73 69.9 1.05 (0.82-1.32) 0.752
Wrist/Hand (S62) 22 28.2 0.78 (0.49-1.18) 0.278
Pelvis/Lumbar spine (S32.0-S32.8) 51 26.5 1.94 (1.44-2.56) <0.001*
Tibia/Ankle (S82) 200 80.5 2.53 (2.19-2.91) <0.001*
Foot (S92) 17 15.5 1.10 (0.64-1.77) 0.793
Femur - neck of (S72.0-S72.2) 293 88.2 3.39 (3.01-3.81) <0.001*
Femur - other (S72.3-S72.8) 58 12.3 4.88 (3.68-6.35) <0.001*
Femur - unspecified (S72.9) 18 2.7 6.91 (4.04-11.09) <0.001*
Fractures excluding those occurring in the
first year after first MS admission
Observed Expected Rate Ratio (95% confidence interval) Exact P value
All fractures‡ 3697 1864.9 2.00 (1.93-2.07) <0.001*
Ribs (S22.2-S22.4) 139 109.7 1.27 (1.07-1.50) 0.006
Clavicle (S42.0) 72 44.8 1.61 (1.26-2.04) <0.001*
Humerus (S42.2-S42.4, S42.7) 339 175.8 1.95 (1.74-2.17) <0.001*
Forearm (S52) 375 423.6 0.88 (0.80-0.98) 0.019
Wrist/Hand (S62) 135 159.9 0.84 (0.71-1.00) 0.053
Pelvis/Lumbar spine (S32.0-S32.8) 242 161.1 1.51 (1.32-1.71) <0.001*
Tibia/Ankle (S82) 1193 425.6 2.86 (2.70-3.03) <0.001*
Foot (S92) 177 80.1 2.24 (1.92-2.60) <0.001*
Femur - neck of (S72.0-S72.2) 1286 486 2.68 (2.54-2.84) <0.001*
Femur - other (S72.3-S72.8) 485 73.5 7.00 (6.37-7.67) <0.001*
Femur - unspecified (S72.9) 70 15.8 4.57 (3.55-5.81) <0.001*
* Significant P value after full Bonferroni correction = <0.004 (most of the high rate ratios, but none of the low rate ratios, are significant on this criterion).
† Only ICD-10 codes are shown; equivalent ICD-9 codes were also used in the analysis.
‡ ICD-10 codes: S02, S12, S22, S32, S42, S52, S62, S72, S82, S92, T08, T10, T12.
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trols per person with MS, i.e. ample numbers of
controls.
The rate ratios for fractures in England are shown in
Table 2. There was an elevated risk for all fractures in
MS patients compared with controls (rate ratio (RR) =
1.99, 95% confidence interval (CI) = 1.93 and 2.05). Ana-
lysis of site of fracture showed that there were elevated
risks for all sites except forearm (RR = 0.91, 0.82-1.00)
and wrist/hand (RR = 0.83, 0.71-0.98). Risks were par-
ticularly high for fractured neck of femur (RR = 2.79,
2.65-2.93), other femoral fracture (RR = 6.69, 6.12-7.29),
and fractures of tibia or ankle (RR = 2.81, 2.66-2.96).
Considering fractures that occurred up to a year after
the first recorded admission for MS, which may reflect
fractures resulting from an MS relapse or treatment,
there was a significantly increased risk for all fractures
combined (RR = 1.94, 1.80-2.08). However, when investi-
gating specific fractures, elevated risks were present only
for fractures of the femur, hip, humerus and tibia/ankle.
There were reduced risks for fractures of the ribs, clav-
icle and forearm.
Considering fractures that occurred at least a year
after admission for MS, there was a significantly
increased risk for all fractures combined (RR = 2.00, 95%
CI = 1.93-2.07). When investigating specific fractures,
elevated risks were seen for all types except forearm and
wrist/hand fractures.
Discussion
Previous studies have highlighted an increased risk of
fractures in patients with MS [6,7].
These previous findings, combined with our own, sug-
gest that there is a general association between MS and
the risk of fractures. There are various potential explana-
tions for this. It has been shown that MS patients are at
an increased risk of osteoporosis. This may be due to
their immobility, the use of glucocorticoids or low vita-
min D levels [4]. We, like others, observed substantially
elevated risks for fractures of the femur, hip and tibia/
ankle, which are typically related to immobility [6]. For
example, our rate ratio for fractured neck of femur was
similar to that in the Danish MS cohort (2.8 and 3.2, re-
spectively), as was our rate for other femoral fracture
(English and Danish figures were both 6.7). The
increased risk for all fractures is present both before and
after the first year following MS admission making
glucocorticoid use unlikely to be the major cause of the
elevated risk. Studies consistently show that bone min-
eral density (BMD) at the femoral neck decreases with
increasing MS-related disability [11]. However, lower
than expected BMD has recently been reported in indi-
viduals newly diagnosed with MS or clinically isolated
syndromes as compared to controls [12] questioning apredominant role for disability. Our finding of an
increased risk of fracture within the first year of admis-
sion and also years afterwards may support this but we
do not have data on disability at admission to appropri-
ately address this.
A key strength of the dataset is its size and the fact
that each individual fracture site could be studied. The
risk of fractures was studied all within a single popula-
tion, using the same methodology, which means that dir-
ect comparisons of risk across fracture sites can be
made. The dataset has limitations. The data is based on
prevalent cases of MS – the first recorded hospital ad-
mission or episode of day case care for each person with
MS – rather than being a cohort with follow-up from
the date of first diagnosis. The dataset is limited to
people who were admitted to hospital, or who received
day case specialist care. We lack treatment and disability
data for MS; these can themselves influence the risk of
fracture. Thus the generalisability of our findings to the
entire MS patient population is unclear. There is very
limited information on potential confounding factors
such as detailed socioeconomic characteristics and eth-
nicity. The effect of making multiple comparisons across
different fracture sites also needs to be considered, but
findings where the significance level is <0.001 or less are
unlikely to be attributable to chance alone.
Conclusion
In summary, we found a significantly elevated risk for
fractures in patients with MS. Many patients with MS
do not take supplemental calcium or vitamin D. Al-
though any beneficial effect of doing so would need for-
mally to be tested, this might be a potential area of
improvement in care to optimize bone health in patients
with MS [13].
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